MTOR and cancer: Similar to amino acid withdrawal, metformin induces a cytosolic withdrawal and inactivation of mTOR from the nucleus.[21] Another group using phosphoproteomics have found that certain mTOR substrates are still positively regulated in cancer cells following metformin treatment and proposed that metformin does not inhibit mTOR but rather rewires its signaling.